Drug intelligence / Profile preview

Shuganhuazhuo Formula

Development stage
Phase 2
Lead developer
Xiang-Qian
Administration
Oral
01

Overview

Shuganhuazhuo Formula (SHF) is a traditional Chinese herbal medicine decoction being investigated for the treatment of advanced hepatocellular carcinoma (HCC), particularly in patients presenting with the Damp-Heat and Blood Stasis syndrome. The formula is composed of several botanical ingredients, including *Bupleuri Radix* (Chaihu), *Scutellariae Radix* (Huangqin), processed *Pinelliae Rhizoma* (Fabanxia), *Ginseng Radix et Rhizoma* (Renshen), *Agrimoniae Herba* (Xianhecao), stir-fried *Arecae Semen* (Chao Binglang), stir-fried *Aurantii Fructus* (Chao Zhiqiao), and *Artemisiae Scopariae Herba* (Yinchen). SHF is designed to improve liver reserve function, which is often compromised by tumor burden, cirrhosis, or anti-tumor treatments. Preclinical studies suggest that the formula can inhibit liver necrosis, reduce fibrosis scores, and provide antioxidant effects. It is currently being evaluated in randomized controlled trials as an adjunctive therapy to standard-of-care treatments such as targeted therapy and immunotherapy to enhance overall survival and quality of life.

02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on Shuganhuazhuo Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuganhuazhuo Formula.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call